Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions. A prospective randomised clinical study on 120 patients

Injury

Volumn 39, Issue 12, 2008, Pages 1391-1402

  Calori, G M ^a   Tagliabue, L ^a   Gala, L ^a   d'Imporzano, M ^a   Peretti, G ^a   Albisetti, W ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone healing; Long bones; Non union; PRP; rhBMP 7

Indexed keywords

RECOMBINANT OSTEOGENIC PROTEIN 1;

ADULT; AGED; ARTICLE; BONE GRAFT; BONE RADIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEMUR; FRACTURE NONUNION; HUMAN; HUMERUS; INTERMETHOD COMPARISON; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIUS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE RICH PLASMA; TIBIA; TREATMENT OUTCOME; ULNA;

ADULT; AGED; BONE MORPHOGENETIC PROTEIN 7; FEMALE; FEMORAL FRACTURES; FRACTURE HEALING; FRACTURES, UNUNITED; HUMANS; HUMERAL FRACTURES; MALE; MIDDLE AGED; OSTEOGENESIS; PLATELET-RICH PLASMA; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TIBIAL FRACTURES; ULNA FRACTURES; YOUNG ADULT;

EID: 57049122787     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2008.08.011     Document Type: Article

References (81)

1. Anitua E., Sanchez M., Nurden A.T., et al. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 24 (2006) 227-234
2. Aspenberg P., Basic N., Tagil M., and Vukicevic S. Reduced expression of BMP-3 due to mechanical loading: a link between mechanical stimuli and tissue differentiation. Acta Orthop Scand 71 (2000) 558-562
3. Bara T., and Synder M. Nine-years experience with the use of shock waves for treatment of bone union disturbances. Ortop Traumatol Rehabil 9 (2007) 254-258
4. Bhandari M., Guyatt G.H., Swiontkowski M.F., et al. A lack of consensus in the assessment of fracture healing among orthopaedic surgeons. J Orthop Trauma 16 (2002) 562-566
5. Bimmel R., and Govaers K. Does harvesting of iliac bone grafts with an acetabular reamer reduce complication rate?. Acta Orthop Belg 72 (2006) 598-602
6. Bong M.R., Capla E.L., Egol K.A., et al. Osteogenic protein-1 (bone morphogenic protein-7) combined with various adjuncts in the treatment of humeral diaphyseal nonunions. Bull Hosp Joint Dis 63 (2005) 20-23
7. Bostrom M.P., Lane J.M., Berberian W.S., et al. Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13 (1995) 357-367
8. Brownlow H.C., Reed A., and Simpson A.H. The vascularity of atrophic non-unions. Injury 33 (2002) 145-150
9. Calori G.M., D'Avino M., Tagliabue L., et al. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. Injury 37 Suppl. 3 (2006) S43-S50
10. Camargo P.M., Lekovic V., Weinlaender M., et al. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 37 (2002) 300-306
11. Carlson E.R. Bone grafting the jaws in the 21st century: the use of platelet-rich plasma and bone morphogenetic protein. Alpha Omegan 93 (2000) 26-30
12. Cheng H., Jiang W., Phillips F.M., et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A (2003) 1544-1552
13. Cho H.S., Park S.Y., Kim S., et al. Effect of different bone substitutes on the concentration of growth factors in platelet-rich plasma. J Biomater Appl (2008)
14. Cierny III G., Mader J.T., and Penninck J.J. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res 414 (2003) 7-24
15. Ciombor D.M., and Aaron R.K. The role of electrical stimulation in bone repair. Foot Ankle Clin 10 (2005) 579-593 vii
16. Cook S.D., Barrack R.L., Patron L.P., and Salkeld S.L. Osteogenic protein-1 in knee arthritis and arthroplasty. Clin Orthop Relat Res (2004) 140-145
17. Crowley D.J., Kanakaris N.K., and Giannoudis P.V. Femoral diaphyseal aseptic non-unions: is there an ideal method of treatment?. Injury 38 Suppl. 2 (2007) S55-S63
18. Dahabreh Z., Dimitriou R., and Giannoudis P.V. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. Injury 38 (2007) 371-377
19. Dallari D., Savarino L., Stagni C., et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 89 (2007) 2413-2420
20. De Long Jr. W.G., Einhorn T.A., Koval K., et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery: a critical analysis. J Bone Joint Surg Am 89 (2007) 649-658
21. de Vasconcelos Gurgel B.C., Goncalves P.F., Pimentel S.P., et al. Platelet-rich plasma may not provide any additional effect when associated with guided bone regeneration around dental implants in dogs. Clin Oral Implants Res 18 (2007) 649-654
22. Dimitriou R., Dahabreh Z., Katsoulis E., et al. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 36 Suppl. 4 (2005) S51-S59
23. Dinopoulos H., and Giannoudis P.V. (iv) The use of bone morphogenetic proteins (BMPs) in long-bone non-unions. Curr Orthopaed 21 (2007) 268-279
24. Einhorn T.A. Enhancement of fracture healing. Instr Course Lect 45 (1996) 401-416
25. Einhorn T.A., Bonnarens F., and Burstein A.H. The contributions of dietary protein and mineral to the healing of experimental fractures: a biomechanical study. J Bone Joint Surg Am 68 (1986) 1389-1395
26. EMEA European public assessment report. procedure: no. EMEA/H/C/293; 2000.
27. Friedlaender G.E., Perry C.R., Cole J.D., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl. 1 (2001) S151-S158
28. Frölke J.P.M., and Patka P. Definition and classification of fracture non-unions. Injury 38 Suppl. 2 (2007) S19-S22
29. Froum S.J., Wallace S.S., Tarnow D.P., and Cho S.C. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodon Rest Dent 22 (2002) 45-53
30. Garg A.K. The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update 11 (2000) 17-21
31. Geesink R.G., Hoefnagels N.H., and Bulstra S.K. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81 (1999) 710-718
32. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88 (2003) 873-884
33. Giannoudis P.V., Dinopoulos H., and Tsiridis E. Bone substitutes: an update. Injury 36 Suppl. 3 (2005) S20-S27
34. Giannoudis P.V., Einhorn T.A., and Marsh D. Fracture healing: a harmony of optimal biology and optimal fixation?. Injury 38 Suppl. 4 (2007) S1-S2
35. Giannoudis P.V., Einhorn T.A., and Marsh D. Fracture healing: the diamond concept. Injury 38 Suppl. 4 (2007) S3-6
36. Giannoudis P.V., Kanakaris N.K., and Einhorn T.A. Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence. Osteoporos Int 18 (2007) 1565-1581
37. Giannoudis P.V., Psarakis S., Kanakaris N.K., and Pape H.C. Biological enhancement of bone healing with bone morphogenetic protein-7 at the clinical setting of pelvic girdle non-unions. Injury 38 Suppl. 4 (2007) S43-S48
38. Giannoudis P.V., and Tzioupis C. Clinical applications of BMP-7: the UK perspective. Injury 36 Suppl. 3 (2005) S47-S50
39. Govender S., Csimma C., Genant H.K., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A (2002) 2123-2134
40. Grauer J.N., Patel T.C., Erulkar J.S., et al. Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine 2001 26 (2000) 127-133
41. Guidance document for the preparation of investigational device exemptions and pre-market approval applications for bone growth stimulator devices (1988), United States Food and Drug Administration, Rockville, MD
42. Gustilo R.B., and Anderson J.T. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am 58 (1976) 453-458
43. Harwood P.J., and Giannoudis P.V. Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects. Expert Opin Drug Saf 4 (2005) 75-89
44. Hayda R.A., Brighton C.T., and Esterhai Jr. J.L. Pathophysiology of delayed healing. Clin Orthop Relat Res (1998) S31-S40
45. Hierholzer C., Sama D., Toro J.B., et al. Plate fixation of ununited humeral shaft fractures: effect of type of bone graft on healing. J Bone Joint Surg Am 88 (2006) 1442-1447
46. International conference of harmonization guideline clinical safety data management: definitions and standards for expedited reporting. Federal Register, March 1, 1995.
47. Jensen T.B., Rahbek O., Overgaard S., and Soballe K. Platelet rich plasma and fresh frozen bone allograft as enhancement of implant fixation. an experimental study in dogs. J Orthop Res 22 (2004) 653-658
48. Jingushi S., Mizuno K., Matsushita T., and Itoman M. Low-intensity pulsed ultrasound treatment for postoperative delayed union or nonunion of long bone fractures. J Orthop Sci 12 (2007) 35-41
49. Kanakaris N.K., and Giannoudis P.V. The health economics of the treatment of long-bone non-unions. Injury 38 Suppl. 2 (2007) S77-S84
50. Kanakaris N.K., Paliobeis C., Manidakis N., and Giannoudis P.V. Biological enhancement of tibial diaphyseal aseptic non-unions-the efficacy of autologous bone grafting: BMPs and reaming by-products. Injury 38 Suppl. 2 (2007) S65-S75
51. Karamitros A.E., Kalentzos V.N., and Soucacos P.N. Electric stimulation and hyperbaric oxygen therapy in the treatment of nonunions. Injury 37 Suppl. 1 (2006) S63-S73
52. Khan S.N., Bostrom M.P., and Lane J.M. Bone growth factors. Orthop Clin North Am 31 (2000) 375-388
53. Kitoh H., Kitakoji T., Tsuchiya H., et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis-a preliminary result of three cases. Bone 35 (2004) 892-898
54. Kontakis G.M., Papadokostakis G.M., Alpantaki K., et al. Intramedullary nailing for non-union of the humeral diaphysis: a review. Injury 37 (2006) 953-960
55. Lane J.M. Bone morphogenic protein science and studies. J Orthop Trauma 19 (2005) S17-S22
56. Lieberman J.R., Conduah A., and Urist M.R. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res (2004) 139-145
57. Lowery G.L., Kulkarni S., and Pennisi A.E. Use of autologous growth factors in lumbar spinal fusion. Bone 25 (1999) 47S-50S
58. Lu C., Miclau T., Hu D., and Marcucio R.S. Ischemia leads to delayed union during fracture healing: a mouse model. J Orthop Res 25 (2007) 51-61
59. Maegawa N., Kawamura K., Hirose M., et al. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med 1 (2007) 306-313
60. Mahendra A., and Maclean A.D. Available biological treatments for complex non-unions. Injury 38 Suppl. 4 (2007) S7-12
61. Maniscalco P., Gambera D., Bertone C., et al. Healing of fresh tibial fractures with OP-1: a preliminary report. Acta Biomed 73 (2002) 27-33
62. Marx R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62 (2004) 489-496
63. Marx R.E., Carlson E.R., Eichstaedt R.M., et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 638-646
64. McKee M.D. Recombinant human bone morphogenic protein-7: applications for clinical trauma. J Orthop Trauma 19 (2005) S26-S28
65. Olson S., and Hahn D. Surgical treatment of non-unions: a case for internal fixation. Injury 37 (2006) 681-690
66. Ozkaynak E., Rueger D.C., Drier E.A., et al. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 9 (1990) 2085-2093
67. Poynton A.R., and Lane J.M. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27 (2002) S40-S48
68. Reed A.A., Joyner C.J., Brownlow H.C., and Simpson A.H. Human atrophic fracture non-unions are not avascular. J Orthop Res 20 (2002) 593-599
69. Roukis T.S., Zgonis T., and Tiernan B. Autologous platelet-rich plasma for wound and osseous healing: a review of the literature and commercially available products. Adv Ther 23 (2006) 218-237
70. Rüedi T.P., and Murphy W.M. Principles of fracture management (2000), Thieme, Stuttgart
71. Sakou T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22 (1998) 591-603
72. Scott J., and Huskisson E.C. Graphic representation of pain. Pain 2 (1976) 175-184
73. Sen M.K., and Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?. Injury 38 Suppl. 1 (2007) S75-S80
74. Thor A., Franke-Stenport V., Johansson C.B., and Rasmusson L. Early bone formation in human bone grafts treated with platelet-rich plasma: preliminary histomorphometric results. Int J Oral Maxillofac Surg 36 (2007) 1164-1171
75. Urist M.R. Bone: formation by autoinduction. Science 150 (1965) 893-899
76. Vaibhav B., Nilesh P., Vikram S., and Anshul C. Bone morphogenic protein and its application in trauma cases: a current concept update. Injury 38 (2007) 1227-1235
77. Veillette C.J., and McKee M.D. Growth factors-BMPs, DBMs, and buffy coat products: are there any proven differences amongst them?. Injury 38 Suppl. 1 (2007) S38-S48
78. Weibrich G., Gnoth S.H., Otto M., et al. Growth stimulation of human osteoblast-like cells by thrombocyte concentrates in vitro. Mund Kiefer Gesichtschir 6 (2002) 168-174
79. White A.P., Vaccaro A.R., Hall J.A., et al. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int Orthop 31 (2007) 735-741
80. Wozney J.M. Bone morphogenetic proteins. Prog Growth Factor Res 1 (1989) 267-280
81. Wrotniak M., Bielecki T., and Gazdzik T.S. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil 9 (2007) 227-238